financetom
Business
financetom
/
Business
/
Bhagiradha Chemicals aims to triple turnover in five years to Rs 1,500 crore
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bhagiradha Chemicals aims to triple turnover in five years to Rs 1,500 crore
Oct 12, 2023 6:38 AM

In an interview with CNBC-TV18, A Arvind Kumar, the CEO & COO of Bhagiradha Chemicals and Industries, shared the company's ambitious plan to triple its revenue within the next five years.

Share Market Live

NSE

Kumar said, “We will be looking at something like 3x kinds of current turnover. Currently, Bhagiradha has Rs 500 crore in turnover in FY23 and we would be looking to target in excess of Rs 1,500 crore in the next five years.”

Hyderabad-based Bhagiradha Chemicals manufactures agrochemicals such as pesticides.

The company also expects a significant enhancement in margins. In FY23, Bhagiradha Chemicals achieved a PAT margin of nearly 10%, and it aims to bolster this figure by an additional 3 to 4% moving forward.

Read Here | Govt notifies changes in PLI scheme for white goods

To fund the growth initiatives, the company plans to issue convertible warrants of up to Rs 340 crore through preferential allotment. However, it's important to note that the company will initially receive only 25% of this amount. The remaining 75% will be disbursed after 18 months.

The funds raised from this process will be channeled into investments in its subsidiary company. Kumar said, "These funds will be utilised to fuel investments in our subsidiary, Bheema Fine Chemicals."

The company has a 34-acre facility in the Kadechur industrial area, and all the raised capital will be reinvested in our subsidiary."

The total projected investment surpasses Rs 700 crore, and Bhagiradha Chemicals anticipates a corresponding surge in the subsidiary's turnover, reaching nearly Rs 1,200 crore. This translates to approximately 1.5 to 1.7 times the initial investment.

Kumar said the company's promoters are actively participating in this expansion, contributing around Rs 15 crore through convertible warrants. This highlights a collaborative approach to growth, with institutional investors, existing shareholders, and even the company's employees showing keen interest in investing in these convertible warrants.

Shares of Bhagiradha Chemicals are stable at Rs 1,634.90. The stock has gained more than 33% over the past month.

(Edited by : Shweta Mungre)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mitsubishi UFG Comments on Yen as Japanese Currency Weakens Against U.S. Dollar
Mitsubishi UFG Comments on Yen as Japanese Currency Weakens Against U.S. Dollar
Jul 14, 2025
06:58 AM EDT, 07/14/2025 (MT Newswires) -- The yen has weakened the most this month among G10 currencies against the U.S. dollar, resulting in USD/JPY hitting a high overnight Sunday of 147.57, said Mitsubishi UFG. The yen has failed to gain support from rising yields in Japan, wrote the bank in a note. The sell-off at the longer end of...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sonnet to Merge With Rorschach, Form $888M Crypto Treasury Firm Hyperliquid Strategies
Sonnet to Merge With Rorschach, Form $888M Crypto Treasury Firm Hyperliquid Strategies
Jul 14, 2025
06:58 AM EDT, 07/14/2025 (MT Newswires) -- Sonnet BioTherapeutics ( SONN ) said Monday it has agreed to merge with Rorschach, backed by Atlas Merchant Capital and Paradigm Operations and will build a reserve of HYPE, the token of the Hyperliquid Layer-1 blockchain. Sonnet said the new entity, Hyperliquid Strategies (HSI), will hold 12.6 million HYPE tokens valued at $583...
BD's Biosciences, Diagnostic Solutions Business to Combine With Waters in $17.5 Billion Deal
BD's Biosciences, Diagnostic Solutions Business to Combine With Waters in $17.5 Billion Deal
Jul 14, 2025
06:59 AM EDT, 07/14/2025 (MT Newswires) -- BD's (BDX) biosciences and diagnostic solutions business has agreed to combine with Waters (WAT), the companies said Monday. The deal is structured as a Reverse Morris Trust transaction valued at about $17.5 billion. BD's shareholders are expected to own about 39% of the merged entity, with existing Waters shareholders to account for the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved